TSX:XLY

Auxly Cannabis Group Inc. · TSX · Healthcare · CAD · FY for 2025

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aCAD

Market data

  • 8.2xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 27.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 15.4%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.32Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CAD
    • computed

Five bars, one line

lens 7 of 9
2.48x
-0.92x
-0.85x
0.52x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales2.48x

    Its own average over 10 years, 61.1M.

  • Profit-0.92x

    Its own average over 10 years, -45.6M.

  • Free cash flow-0.85x

    Its own average over 10 years, -27.4M.

  • Debt0.52x

    Its own average over 9 years, 111.8M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at -0.92 times.

Sales is 2.48 times its own 10-year average; Profit is -0.92 times its own 10-year average; Free cash flow is -0.85 times its own 10-year average; Debt is 0.52 times its own 9-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average2.48
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CAD
  • Profit against its own 10-year average-0.92
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CAD
  • Free cash flow against its own 10-year average-0.85
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CAD
  • Debt against its own 9-year average0.52
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CAD
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    CAD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.